A non-core eye care business that was spun off from Novartis.
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Alcon Inc. in the last 30 days yet.
The 2 sources with the most insights about Alcon Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Global install base of over 30,000 surgical units drives a high-margin razor-and-blade consumable model, supporting expected mid-teens earnings growth and valuation expansion.
Mentioned as a non-core business spun off by Novartis as part of a strategy that unlocked approximately $180 billion in shareholder value.
Global install base of over 30,000 surgical units drives a high-margin razor-and-blade consumable model, supporting expected mid-teens earnings growth and valuation expansion.
Mentioned as a non-core business spun off by Novartis as part of a strategy that unlocked approximately $180 billion in shareholder value.
Other assets that creators frequently mention in the same content as Alcon Inc..
The most active sources covering Alcon Inc. (ALC) on Kazuha are The Joseph Carlson Show, Andreessen Horowitz. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 2 AI-extracted insights about Alcon Inc. (ALC) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Alcon Inc. (ALC) most frequently also discuss GSK, SDZ, META, IONS, MSFT. See the "Discussed alongside" section above for full asset pages.